Discover, explore & compare companies within the Healthcare Sector from the NASDAQ Stock Exchange (NASDAQ). Download the latest price data & trading signals

Jazz Pharma Plc has initiated a negative volume rate of change of -30
Volume Rate of Change /
Jazz Pharma Plc has initiated a negative volume rate of change of -30

[BEARISH CROSSOVER]: Jazz Pharma Plc currently has negative rate of change of -30%. This means the current volume is less than the price 14 days ago and therefore losing momentum. Currently, the return on momentum is -0.7%.

Arena Pharmaceutical is no longer overbought [Neutral]
Relative Strength Index /
Arena Pharmaceutical is no longer overbought [Neutral]

ARNA: RSI Current Signal -> (1) 20 Oct: BEARISH (2) 19 Oct: BEARISH (3) 18 Oct: BEARISH

Price Range /
Recent trading for Paratek Pharma fell short of the previous price range ($0.7)

[BEARISH]: Paratek Pharma current downtrend in the first timeframe. Currently, the Range is $0.7.

Average Directional Movement /
Versartis: Average Directional Index (48.77) has confirmed a strong trend is present

[Trend]: ADX for VSAR has confirmed a strong trend is presentVersartis has an ATR(14) of 0.692, a DX of 51.24 & an ADX(14) of 48.77

Average True Range /
Axogen: ATR (0.538) has signalled an downtrend is current

[Bearish]: Average True Range has confirmed an downtrend is present. Axogen has a TR of 0.5, and an ATR(14) of 0.538.

Short Trend /
Daily trading again produced an Downtrend bar for Alexion Pharm Inc

[BEARISH]: Alexion Pharm Inc is in a downtrend in the short term timeframe. The current rally number is 3 & the highest rally count for the LTM is 3

Top companies for
NASDAQ Stock Exchange
Advertisment
Exponential Moving Average /
[Uptrend]: Recent trading for ATRC indicates ST trend is likely to continue

ATRC: EMA(5) Recent Trading -> (1) 20 Oct: 22.7826 (2) 19 Oct: 22.7589 (3) 18 Oct: 22.6883

Buying pressure for ANI Pharmaceuticals continues - bullish signal
Chaikin Money Flow /
Buying pressure for ANI Pharmaceuticals continues - bullish signal

[BULLISH]: ANI Pharmaceuticals current price has highlighted recent buying pressure and the continuation of a bullish trading conditions. Currently, the CMF is 0.1. The bullish signal has been active for 0 day. During the quarter, the highest CMF value was 0.19

IDXX: Over the last 12 months there has been 48 trading days with the opening price in the lower shadow & the closing the price in the upper shadow
Open Tod Vs Close Tod /
IDXX: Over the last 12 months there has been 48 trading days with the opening price in the lower shadow & the closing the price in the upper shadow

IDXX: Open today versus close yesterday Current Signal ->(1) 20 Oct: BULLISH STRONG (2) 19 Oct: BEARISH WEAK (3) 18 Oct: BULLISH STRONG

Open Tod Vs Close Tod /
Cardiovascular Syst opened in the upper part of daily range at 87% & closed in the middle part of the trading range at 36.4%. This suggests the sellers have lost commitment.

[BEARISH WEAK]: Cardiovascular Syst opened in the upper part of daily range at 87% & closed in the middle part of the trading range at 36.4%. This suggests the sellers have lost commitment. Over the last 12 months there has been 27 trading days with the opening price in the upper shadow & the closing the price in the middle shadow giving a confirmation ratio of 10.3%. Over the last month there has been 3 trading days with the opening price in the upper price range & the closing the price in the middle price range giving a confirmation ratio of 20%.

Fibonacci Extensions /
Insys Theraptcs: 1.618 Fibonacci Extension ($12.19)

Insys Theraptcs has moved below the 161.8% level ($17.11) [Bullish]. Look for a long limit order entry near this point. Exit price for INSY should be set @$12.85 & Stoploss for Insys Theraptcs should be set at $21.37

Price Range /
Price volatility is low for AXGN based on the lower price range ($0.48) [Downtrend]

[BEARISH]: Axogen current downtrend in the first timeframe. Currently, the Range is $0.48.

Keryx Biopharm Inc is in a short term downtrend with the resistance price @$6.62554
Exponential Moving Average /
Keryx Biopharm Inc is in a short term downtrend with the resistance price @$6.62554

KERX: EMA(5) Current Signal -> (1) 20 Oct: BULLISH (2) 19 Oct: BULLISH (3) 18 Oct: BULLISH

Stochastic Oscillator for AMAG is still below the oversold limit signalling a bullish movement
Stochastic Oscillator /
Stochastic Oscillator for AMAG is still below the oversold limit signalling a bullish movement

[BULLISH]: Amag Pharmaceuticals is currently Oversold highlighting the potential for a short term trend reversal in the upward direction.

Exponential Moving Average /
The EMA trend following signal is still current for La Jolla Pharma [Bullish]

[BULLISH]: La Jolla Pharma currently has a confirmed uptrend. Recent trading has caused the EMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on EMA5 is 0.4%.

Demarks Pivot Points /
[Long]: Entry price for KTWO should be set @$20.02

K2M current pivot point (DeMark) is: (R1) $20.24. The current pivot point (DeMark) is: (S1) $19.89.

Price Range /
Range for DEPO has not surpassed the range of the previous trading session

DEPO: Price Range Current Signal -> (1) 20 Oct: BEARISH (2) 19 Oct: BULLISH (3) 18 Oct: BEARISH

CMF showing buying pressure & potential change in direction for BIIB
Chaikin Money Flow /
CMF showing buying pressure & potential change in direction for BIIB

[BULLISH]: Biogen Inc Cmn current price has highlighted recent buying pressure and the continuation of a bullish trading conditions. Currently, the CMF is 0.22. The bullish signal has been active for 1 day. During the quarter, the highest CMF value was 0.24

PPO: The shorter moving average for PRSCis still above the longer term moving average
Percentage Price /
PPO: The shorter moving average for PRSCis still above the longer term moving average

[BULLISH]: Providence Svc currently has positive PPO 1.700%. This means the current price is gaining momentum through a rise on the short term exponential moving average.

QDEL: Current trading activity signals DVI accumulation is active
Daily Volume Index /
QDEL: Current trading activity signals DVI accumulation is active

[BULLISH]: Quidel current accumulation has given strength to the share price and the continuation of bullish trading conditions.

Demarks Pivot Points /
Alexion Pharm Inc: Look for a short limit order entry @$138.615

Alexion Pharm Inc has broken the first DeMark support point ($138.615) [Bearish]. Look for a short limit order entry near this point. Exit price for ALXN should be set @$136.75 & short position stoploss for Alexion Pharm Inc should be set at $139.75

Commodity Channel Index /
Alkermes Plc: The CCI oversold signal has been confirmed

[BULLISH CROSSOVER]: Alkermes Plc current price has driven Commodity Channel Index to become oversold signalling the start of bullish trading conditions. Currently, the CCI is -124. During the quarter, the lowest CCI value was -147. The last oversold signal occurred on Oct 17 2017

On Balance Volume /
Recent trading signals Vanda Pharmaceutical is being accumulated

[BULLISH]: Vanda Pharmaceutical current price has highlighted recent accumulation. Currently, the OBV is 3.8873e+006.

Sine Weighted Moving Average /
K2M is in a short term uptrend with the closing price @$19.98

[BULLISH]: K2M currently has a confirmed uptrend. Recent trading has caused the SWMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SWMA5 is 1.2%.

Positive momentum on the volume MACD histogram for UTHR is maintained & supports a bullish move is likely
MACD Volume /
Positive momentum on the volume MACD histogram for UTHR is maintained & supports a bullish move is likely

UTHR: Volume MACD Current Signal -> (1) 20 Oct: BULLISH (2) 19 Oct: BULLISH CROSSOVER (3) 18 Oct: BULLISH CROSSOVER

Axogen: Daily low performance is 2.9 % [Uptrend]
Low Price /
Axogen: Daily low performance is 2.9 % [Uptrend]

[BEARISH]: Axogen current uptrend in the first timeframe. Currently, the Low is $19.92 (2.9 %).

GROWTH /
Aduro Biotech: Book value is $3.50

Aduro Biotech Key financial metrics: (1) Book Value: $3.50 (2) Market-to-Book ratio: 2.64 (3) PEG Ratio:

See More   See more results
Advertisment
Advertisment
back to top